Introduction
Human rhinoviruses (HRVs), the main causative agent of the common cold, have been classified into two groups according to their binding specificity for the minor or the major group rhinovirus receptor (Lonberg-Holm et al., 1976; Abraham & Colonno, 1984; Uncapher et al., 1991) . The rhinovirus major group receptor has recently been shown to be identical to the intercellular adhesion molecule ICAM-1. Because of its importance for cell-cell interaction, ICAM-1 has been the subject of extensive studies (for review see Springer, 1990) . Thus, a wealth of data on this surface protein is now available through the joint effort of virologists and cell biologists Greve et al., 1989; Staunton et al., 1989 Staunton et al., , 1990 Tomassini & Colonno, 1986; Tomassini et al., 1989) . The majority of rhinovirus serotypes (91 of 102 tested) attach to this protein (Uncapher et al., 1991) . Of the remaining rhinoviruses, 10 serotypes enter the cell via the rhinovirus minor group receptor. This membrane protein has been partially purified from HeLa cells and has been characterized to a limited extent (Mischak et al., 1988a, b) . Recently, HRV-87 has been shown to be unique in binding to a third protein, different from the minor and the major group receptors (Uncapher et al., 1991) .
Since all cell lines examined so far have been shown to bind rhinoviruses of the minor group type (Uncapher et al., 1991) , DNA transfection methods cannot be employed for the identification of the minor group receptor. Such techniques were used for the isolation of the genes encoding the poliovirus receptor (Mendelsohn et al., 1986) and the major group rhinovirus receptor (Greve et al., 1989) . The ubiquitous presence of the minor group receptor might also explain the failure to obtain antibodies against this protein. We therefore chose to enrich the receptor protein by classical biochemical means (Mischak et al., 1988a) .
To obtain a soluble form of the rhinovirus minor group receptor which could be purified in the absence of detergents, we tried to release the protein by enzymic treatment of HeLa cells. In the course of these experiments we discovered that substantial amounts of a virus-binding protein were shed into the buffer upon incubation at 37 °C even in the absence of any enzymes. Closer analysis of this process revealed that the virusbinding activity is released by a process which requires the presence of Ca ions and can be blocked by EDTA and 1,10-phenanthroline, both being inhibitors of phospholipases and/or certain proteases.
Rueckert, University of Wisconsin, Madison, Wis., U.S.A.) were grown in monolayers in MEM (from PAA) supplemented with 10% foetal calf serum (FCS), 2 mM-glutamine, 100 units/ml penicillin and 10 ktg/ml streptomycin. Cells (4 x 107) were seeded into 500 ml spinner flasks and grown to about 5 x 10S/ml in Joklik's modified MEM containing 7% horse serum, 2% FCS and 2 mM-glutamine (all from PAA). For growth in serum-free medium (Barnes, 1987) , cells were washed, seeded in F12 medium (Flow Laboratories) supplemented with 10 ng/ml EGF, 100 ng/ml FGF, 18 ng/ml hydrocortisone, 1/100 (v/v) trace element mix, and 1% ITS+ cell growth system. The cells were grown for 2 days before assaying for virus-binding activity.
Enzymicdigestions.HeLacells(1 x 107)fromsuspensioncultureswere pelleted, washed twice with ice-cold PBS and suspended in 1 m120 mM-HEPES pH 7-0, 120 mM-KCI containing 5 mM-MgC12 (HEPES buffer). Incubation of cells with enzymes was carried out at an enzyme concentration of 20 I-tg/ml for 1 h at 37 °C. Papain was activated in 200 m~-phosphate buffer pH 7.0, 2 mM-EDTA, 5 mM-L-cysteine, 5 mM-DTT for 10 min at 37 °C followed by desalting on a PD10 column (Pharmacia). During the course of the experiments it was found that essentially the same results were obtained when PBS was used in place of HEPES buffer.
Cells were pelleted and assayed for virus-binding activity. The supernatants were concentrated to 20 ~tl using Centricon 10 microconcentrators (Amicon) and were analysed by ligand blotting as described previously (Mischak et al., 1988b) . For determination of the time course of regeneration of membranebound receptors the binding assays were done for 10 min at 25 °C using HRV-2 labelled with [125I] by the Iodogen method (Markwell & Fox, 1978) .
Affinity chromatography on Jacalin agarose. Fresh cell culture medium (10 ml) was loaded onto a Jacalin agarose column (2 ml) equilibrated in PBS. The column was washed until the A280 returned to zero, and bound material was eluted in 10 ml PBS containing 100 mMmethyl-~-D-galactopyranoside. The eluate was concentrated to 20 p.l on Centricon microconcentrators and subjected to ligand blotting.
Results

Release o f soluble virus-binding activity and enzymic treatment o f HeLa cells
T o assess the possibility o f solubilizing the m i n o r g r o u p r e c e p t o r f r o m t h e cell surface, H e L a cells w e r e i n c u b a t e d in the p r e s e n c e or a b s e n c e o f v a r i o u s hydrolytic e n z y m e s . T h e s u p e r n a t a n t s w e r e c o n c e n t r a t e d a n d p r o c e s s e d for l i g a n d blotting using 35S-labelled H R V -2 ( M i s c h a k et al., 1988b), a n d the cell pellets w e r e assayed for virus b i n d i n g . F o r c o m p a r i s o n , H e L a cell m e m b r a n e s w e r e e x t r a c t e d w i t h buffer c o n t a i n i n g 1 % octylglucoside, the d e t e r g e n t -s o l u b l e r e c e p t o r a c t i v i t y was purified a n d the m a t e r i a l s u b j e c t e , 1988a, b) . T h i s s a m p l e g a v e rise to two b a n d s o f v i r u s -b i n d i n g a c t i v i t y at 120K and 100K ( Fig. 1 a, lane  1) . T h e s e t w o b a n d s w e r e a b s e n t in the s u p e r n a t a n t o
b t a i n e d f r o m the i n c u b a t i o n w i t h p a p a i n (lane 3), p h o s p h o l i p a s e C (lane 4) or trypsin (lane 5). U n e x p e c t e dly, h o w e v e r , t w o p o l y p e p t i d e s w i t h v i r u s -b i n d i n g a c t i v i t y a p p e a r e d in the control s a m p l e w h i c h h a d b e e n i n c u b a t e d w i t h H E P E S buffer a l o n e (lane 2). T h e s e p o l y p e p t i d e s m i g r a t e d w i
t h a n a p p a r e n t size o f 100K a n d 85K, respectively. T h e u p p e r b a n d (100K) was seen at the s a m e p o s i t i o n as the l o w e r M r species o f the t w o v i r u s -b i n d i n g activities f o u n d in extracts o f m e m b r a n e s treated with octylglucoside (lane 1). This 100K band has previously been shown to be a minor component in the membrane extracts whereas a prominent band had been found to exhibit a size of about 120K (Mischak et al., 1988b) . During the course of the experiments, we observed that the ratio between the 120K and the 100K bands in octylglucoside extracts of membranes was highly variable and possibly dependent on the growth conditions of the cells. The dominant band of virusbinding activity shed into the buffer appeared at a position corresponding to about 85K (lane 2). Only very weak, diffuse bands at positions corresponding to about 50K and 40K appeared upon prolonged exposure of the X-ray film in the samples obtained from the incubations with papain (lane 3) and trypsin (lane 5) respectively. These bands probably correspond to proteolytic fragments that retain marginal binding activity. Under the same conditions, some residual activity was also seen in the sample incubated with phospholipase C as a smear appearing at a position around 80K to 90K (lane 4).
The ability of the treated cells to bind virus was assayed by incubating the cell pellets with radioactive HRV-2 (Table 1) . Samples of cells incubated in HEPES buffer for 1 h bound HRV-2 to an extent similar to cells directly taken from the spinner culture (control). Phospholipase C and papain reduced the membrane-associated receptor activity to about 25 ~ and 14 ~ of the control, respectively. Virus binding was reduced to about 16~ upon digestion with trypsin.
To determine whether proteolytic cleavage is responsible for the shedding of the binding activity, the influence of various protease inhibitors was examined. Leupeptin, pepstatin and PMSF had no effect on the liberation of virus-binding polypeptides (data not shown), whereas EDTA suppressed the release (Fig. 1 b,  lane 4) . A direct effect of the complexing agent on the solubilized binding activity can be excluded since EDTA-containing buffers are employed for the purification of receptor activity (Mischak et al., 1988a) . The inhibition of shedding by EDTA could be explained by assuming the involvement of a metalloprotease; therefore the influence of phosphoramidone, an inhibitor of metalloproteases, and the effect of EGTA and various divalent cations was assessed. When compared to the control (Fig. l b, lane 1) , phosphoramidone slightly decreased the liberation of soluble, binding activity (lane 2), whereas the release was completely blocked by EGTA which specifically complexes Ca ions (lane 3). Furthermore, it was found that only Ca ions were able to counteract the effect of EDTA when present in excess (lane 5), whereas Mg or Zn ions showed no effect (lanes 6 and 7 respectively).
As certain phospholipases which cleave the glycosylphosphatidylinositol anchor of a variety of membrane proteins (Low & Saltiel, 1988) as well as some metalloproteases (Lyons et al., 1991) are Ca2+-dependent, the effect of the phospholipase inhibitor 1,10-phenanthroline was tested. Shedding of virus-binding activity was strongly reduced in the presence of 50 ~tM-phenanthroline (not shown), and completely inhibited at 200 ~tM (lane 8).
Growth of HeLa cells in defined medium
To exclude the possibility of HRV-2-binding activity being present in the medium used to grow the cells, a simple method for removing the bulk of serum proteins was devised. Since HRV-2-binding polypeptides were found to be retained on Jacalin agarose (data not shown), fresh cell culture medium was passed over such an affinity column and the eluted material was analysed. The ligand blot showed that no virus-binding activity was present in fresh cell culture medium. However, cells grown in serum-free medium shed binding activity indistinguishable from the material obtained from cells grown in serum-containing medium (data not shown). These data clearly exclude the presence of polypeptides with virus-binding activity in the cell culture medium.
Soluble rhinovirus minor group binding protein is not associated with membrane fragments
Membrane proteins can be released by shedding as vesicular material (Sachs et al., 1980; Emerson & Cone, 1981) , in a soluble form following cleavage by membrane-bound proteases (Chitambar & Zivkovic, 1989; Porteu & Nathan, 1990) , or by secretion of a truncated protein lacking the membrane anchor (Pure et al., 1984; Mosley et al., 1989; Nophar et al., 1990; Petch et al., 1990; Goodwin et al., 1990) . Recently, a soluble form of the poliovirus receptor has also been described (Koike et al., 1990) . We thus examined the sedimentation properties of the material released upon incubation at 37 °C. HRV-2--binding material was obtained by incubating 5 x l06 HeLa cells in 1 ml HEPES buffer for 60 min at 37 °C. The cell supernatant was centrifuged at 300000 g for 1 h in a no. 65 rotor. Ligand blotting of the supernatant (concentrated to 20 ktl) and of the pelleted material showed that virus-binding activity was present only in the supernatant (data not shown). This proves that the HRV-2-binding activity is not released in vesicular form, but rather as soluble material.
Time course of the release of rhinovirus minor group binding activity
To study the shedding process in more detail, release of HRV minor group binding polypeptides was determined at 37 °C as a function of incubation time. The results indicate that the release is evident at 30 min and attains its maximum after 45 min (Fig. 2) . We then assessed whether the binding protein was released by an energyrequiring mechanism. Cells were incubated either at 37 °C in the presence of 15 raM-sodium azide, or the incubation was carried out at 4 °C. Whereas the release was not affected by azide, no virus-binding activity was detected in the supernatant upon incubation at 4 °C (data not shown).
Regeneration of virus-binding activity after trypsin treatment of HeLa cells
Although a substantial amount of virus-binding activity was released into the supernatant upon incubation with HEPES buffer, no change of virus binding to the cells was observed (Table 1) . We therefore examined whether an intracellular pool of receptor was responsible for this phenomenon by assaying the regeneration of virus Fig. 3 . Time course of the regeneration of surface-bound receptor after trypsin treatment of HeLa cells. Cells (1.5 x 108) were suspended in 150 ml Earle's salts in the presence ( 0 ) or absence (©) of 100 ~tg/ml cycloheximide added for 1 h and were then incubated with 0.1% trypsin at 25 °C for 60 min. Trypsin was blocked by addition of20% FCS and the cells were pelleted. The cell pellet was suspended in 180 ml cell culture medium containing serum with or without cycloheximide. At the time points indicated, samples of 20 ml were removed and the cells were assayed for virus-binding activity.
binding to the cell membrane after the removal of surface-bound receptor with trypsin. As shown in Fig. 3 , HRV binding to the cell surface was rapidly restored. De novo protein synthesis was not required for this process, since no difference was seen when the cells were preincubated with cycloheximide, indicating that a considerable intracellular pool of receptor is present.
Soluble minor group rhinovirus binding protein attaches to HR V-2 in solution
It has been shown previously that coxsackie B virus, poliovirus as well as HRV of the major receptor group were able to bind to their respective detergent-solubilized receptors in solution (Mapoles et al., 1985; Kaplan et al., 1990; Greve et al., 1989) . We therefore examined whether the soluble binding activity would also attach to rhinovirus of the minor group type under similar conditions; purified HRV-2 (Skern et al., 1984) was incubated with a preparation of soluble virus-binding activity in the presence of 30 mM-MgCI2 and 2 mM-CaC12 and the mixture was pelleted through a sucrose cushion. As controls, parallel experiments were carried out with purified HRV-14 (a member of the major group), with HRV-2 inactivated by incubation at 56 °C for 30 min (Lonberg-Holm & Yin, 1973) , or in the absence of virus. The pellets were suspended in Laemmli sample buffer without 2-mercaptoethanol (Laemmli, 1970) and incubated at 56 °C for 30 min in order to dissociate any possible complexes of virus and its binding protein. The mixture was then subjected to electrophoresis and ligand blotting. A band corresponding to the 85K minor group binding activity was present only in the sample containing HRV-2. No binding activity was observed in the control samples either containing HRV-14 or heated HRV-2, or without virus (data not shown). These experiments clearly demonstrate that the soluble rhinovirus minor group binding polypeptide attaches specifically to HRV-2 during the formation of a stable complex.
Discussion
Several cell membrane receptors have recently been shown to exist in a membrane-bound as well as in a secreted form (Mosley et al., 1989; Goodwin et al., 1990) . During experiments in which we aimed to solubilize the HRV minor group receptor with hydrolytic enzymes we discovered that virus-binding activity was shed into the medium by mere incubation at 37 °C in the absence of enzymes. The major form of this released rhinovirus minor group binding activity corresponds to a polypeptide of 85K (Fig. 1) . Despite the extensive shedding, no decrease of virus binding to the cell surface was observed upon incubation in PBS or HEPES buffer at 37 °C for 1 h. Assuming that the soluble virus-binding protein(s) is (are) degradation product(s) of the membrane receptor, only a small fraction of this receptor might be accessible for the virions; therefore loss due to degradation might escape detection. It is also possible that the shed material is immediately replaced by molecules from an otherwise inaccessible pool. As a further alternative, the released virus-binding polypeptides might be replaced by newly synthesized receptor molecules. However, the lack of effect of the protein synthesis inhibitor cycloheximide on the time course of the regeneration of virus binding activity after digestion with trypsin clearly excludes the latter possibility (Fig. 3) . Incubation of cells with papain, phospholipase C or trypsin led to a strong reduction of virus binding; concomitantly, apparent degradation products with a barely detectable binding activity appeared in the supernatant (Fig. 1 a, lanes 3 to 5) . As soluble binding activity remained intact when incubated with phospholipase C in the absence of ceils (data not shown), some unknown (possibly proteolytic) factor must also be released by this enzyme which then inactivates the protein. 1,10-Phenanthroline inhibited shedding of the virus binding activity, indicating either a membranebound phospholipase responsible for release of the rhinovirus minor group binding activity (Low & Saltiel, 1988) or a metalloprotease sensitive to this inhibitor (Lyons et al., 1991) . Alternatively, the action of the putative phospholipase might activate a proteinase which would then cleave the receptor off the cell membrane.
Since cells grown in serum-free medium bound virus in a manner indistinguishable from control cells (data not shown), an attachment mechanism involving a serum component as a mediator of binding can be excluded. Such a mechanism has been proposed for herpes simplex virus where FGF has been suggested to act as a vehicle for binding of the virus to the FGF receptor (Kaner et al., 1990) .
The significance of the release of virus-binding activity is presently unknown. The observation that some membrane receptors are found in soluble form in body fluids might indicate that such a process also occurs in vivo under normal physiological conditions. Nevertheless, it cannot be excluded at the present time that the release of the minor group HRV-binding protein is a consequence of the cell culture system. However, this phenomenon is very useful for obtaining virus-binding activity in a soluble form that is suitable for the characterization of the biochemical properties of this molecule. Further investigation should elucidate the relationship between the membrane-bound receptor and the soluble virus-binding polypeptides, and provide evidence for the mode of interaction of the minor group viruses with their receptor.
